Market Overview

Stocks Hitting 52-Week Highs

Share:
Related MDVN
More Pharma Deals In The Pipeline?
'Delivering Alpha' Conference Has Been Known To Move Stocks
Novel Checkpoints Add To The Parp Showdown (Seeking Alpha)
Related TEVA
Mike Khouw Sees Unusual Options Activity In Teva Pharmaceutical
Watch These 7 Huge Call Purchases In Friday Trade
Amgen Migraine Drug Likely To Beat Eli Lilly, Alder, Teva To Market (Investor's Business Daily)

Medivation (NASDAQ: MDVN) shares touched a new 52-week high of $86.54 after the company and Astellas reported final results from the Phase 3 PREVAIL trial of Enzalutamide. Credit Suisse lifted the price target on Medivation from $80.00 to $95.00.

Teva Pharmaceutical Industries (NYSE: TEVA) shares reached a new 52-week high of $45.60 after the company reported the FDA approval of three-times-a-week COPAXONE 40mg/mL.

CBRE Group (NYSE: CBG) shares jumped 1.54% to touch a new 52-week high of $27.06. CBRE Group is expected release its Q4 financial results on February 5, 2014.

Jones Lang LaSalle (NYSE: JLL) shares surged 5.69% to reach a new 52-week high of $112.36 after the company reported stronger-than-expected Q4 results.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers

 

Related Articles (CBG + JLL)

View Comments and Join the Discussion!